This inventor holds 1 USPTO granted patent. Top assignees: Grelan Pharmaceutical Co., Ltd., Nisshin Flour Milling Co., Ltd.. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Noriyuki Misaki: Innovator in Anti-Ulcer Agents
Introduction
Noriyuki Misaki is a notable inventor based in Inagi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer agents. His innovative work has led to the creation of a patent that addresses important health concerns.
Latest Patents
Misaki holds a patent for "Isoprenoid derivatives and anti-ulcer agents containing the same." This patent focuses on anti-ulcer agents that incorporate isoprenoid derivatives. The isoprenoid derivatives are represented by a specific chemical formula, which includes various groups that can be hydrogen atoms, hydroxy groups, lower alkanoyloxy groups, lower alkyl groups, or lower alkoxy groups. The patent emphasizes the importance of these derivatives in the formulation of effective anti-ulcer medications. He has 1 patent to his name.
Career Highlights
Throughout his career, Misaki has worked with prominent companies in the pharmaceutical and food industries. Notable among these are Nisshin Flour Milling Co., Ltd. and Grelan Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative solutions for health-related issues.
Collaborations
Misaki has collaborated with esteemed colleagues, including Kazuhiko Yamada and Yoshiyuki Tahara. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.
Conclusion
Noriyuki Misaki's contributions to the development of anti-ulcer agents highlight his innovative spirit and dedication to improving health outcomes. His patent and collaborations reflect his commitment to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile